Skip to main content
BMJ Open logoLink to BMJ Open
. 2018 Oct 18;8(10):e022055. doi: 10.1136/bmjopen-2018-022055

Body mass index, waist-to-hip ratio and cognitive function among Chinese elderly: a cross-sectional study

Tao Zhang 1, Rui Yan 1, Qifeng Chen 2, Xuhua Ying 3, Yujia Zhai 1, Fudong Li 1, Xinyi Wang 1, Fan He 1, Chiyu Ye 1, Junfen Lin 1
PMCID: PMC6196809  PMID: 30341119

Abstract

Objectives

To investigate the associations between body mass index (BMI), waist-to-hip ratio (WHR) and cognitive function among Chinese elderly.

Design

Cross-sectional study.

Setting

Community.

Participants

Data were obtained from the baseline survey of a community-based cohort in Zhejiang Province, and 9326 persons aged 60 years and older were enrolled.

Primary outcome measures

We investigated the association between BMI and cognition, and then explored the association between WHR and cognition across different quartiles of BMI.

Results

A sample of 9087 persons was used in this study, including 4375 men and 4712 women. Higher WHR increased cognitive impairment risk in those with BMI >25.3 kg/m2 (OR (per 0.1 increase) 1.39; 95% CI 1.13 to 1.70). No statistically significant association was found in other BMI categories.

Conclusions

Higher WHR could increase the risk of cognitive impairment among elderly with BMI >25.3 kg/m2. Our results suggest that it could be of benefit to the elderly with high BMI to control WHR.

Keywords: cognitive impairment, body mass index, abdominal obesity, elderly, chinese


Strengths and limitations of this study.

  • The strength of this study was the in-depth analysis of the association between waist-to-hip ratio and cognitive impairment across different body mass index categories.

  • High-fat diet, which is an important influence factor for cognitive function, was not included in this study.

  • Since this was a cross-sectional study, caution would be needed when generalising the present findings.

Introduction

Cognitive impairment is an important health issue in the elderly. According to Alzheimer’s Disease International (ADI),1 an estimated 46.8 million people currently have dementia in the world, the most well-known form of cognitive impairment, and this number will rise to 131.5 million in 2050. ADI estimated over 9.5 million people with dementia in China which was 20% of the total number of dementia cases in the world. By 2030, the number of people living with dementia in China is expected to rise to over 16 million. The incidence of dementia in people aged 60 years and older is 9.87 cases per 1000 person-years in China,2 and the situation of cognitive impairment would be more serious.3

Obesity was normally recognised as an influence factor of dementia.4 5 The possible reasons included inflammation and β-amyloid metabolism which had been shown to be linked to obesity.6 However, studies on the association between BMI and cognitive impairment in the elderly have shown conflicting results: both positive and negative association have been reported.7–11 There is a limitation of BMI when comparing individuals with the same weight and height but different body fat mass. BMI is affected by both fat and fat-free mass which may have opposite effects on health.12 Using BMI as a surrogate for obesity may be particularly problematic in the elderly due to the effect of ageing on fat distribution.13 Waist-to-hip ratio (WHR), as a proxy for body fat distribution, would be a complementary indicator in health-related studies for the elderly. It has been reported that high WHR was associated with adverse health outcomes independent of BMI.14 15 Actually, high WHR could increase death even with normal BMI.16 17 Therefore, it would be necessary to evaluate the effect of WHR when BMI was within a certain range.

However, to our knowledge, studies evaluating the association between BMI-specific WHR and cognitive impairment in a large Chinese elderly population were lacking. To help shed light on this area, we investigated the associations between BMI, WHR and cognitive impairment among Chinese aged 60 years and older.

Materials and methods

Study population

The present study used data collected from the baseline survey of a community-based cohort study focusing on ageing and health problems among the elderly in Zhejiang province, China, since 2014. In brief, 6 out of 90 counties were randomly selected from Zhejiang province, with at least 1500 participants randomly recruited in each county for participation in 2014. Inclusion criteria were as following: (1) permanent residents who lived for over 6 months in the past year, (2) aged 60 years and above. Exclusion criterion was an inability to complete the interview due to physical disability. Finally, 9326 subjects were enrolled, with a response rate of 76%. During the baseline survey, we performed questionnaire-based interview, physical examinations and laboratory tests for each participant. A total of 239 participants were excluded because of missing values in age, Chinese language version of the Mini-Mental State Examination (MMSE) score, or BMI, leaving 9087 available for analyses.

Cognitive function

Cognitive function was determined by MMSE which included 30 items. The maximum score of MMSE is 30, and higher scores indicate better cognitive function. According to Wang et al, the questionnaire of MMSE has good reliability and validity as an instrument to detect cognitive impairment among Chinese.18 The cut-off score of cognitive impairment is education-specific: 17/18 for illiteracy, 20/21 for people with primary education level, 24/25 for people with higher than primary education level.19

Body mass index

Body mass index (BMI; kg/m2) was calculated as a person’s body weight (in kilograms) divided by the square of the body height (in metres). Body weight and height were measured by digital weight and height scale, respectively. All the participants were asked to remove shoes, heavy clothing and hats prior to height and weight measurements, and had the participants stand straight with heels together, legs straight and looking straight ahead.

Waist-to-hip ratio

Waist circumference was measured midway between the lower rib margin and the iliac crest, with a soft cloth tape measure. Hip circumference was measured at the level of the widest circumference over the greater trochanters, with a soft cloth tape measure. In the baseline survey, waist circumference and hip circumference were measured twice, and the difference of two measured values was restricted in ±2 cm. WHR was calculated as a person’s waist circumference divided by the hip circumference. In this study, waist circumference and hip circumference were calculated as the mean of two measured values.

Covariates

Covariates were collected by face-to-face interview with questionnaire, including: age, race, education level (self-reported), marital status (self-reported), economic status (self-reported), smoking (self-reported), alcohol drinking (self-reported), physical exercise (activities which were carried out to sustain or improve health and fitness in one’s spare time), hypertension (diagnosed by doctors), diabetes (diagnosed by doctors), coronary heart disease (diagnosed by doctors) and depressive symptom. Depressive symptom was determined using the Patient Health Questionnaire-9 scale. Those who scored 5 or above were defined as depression.20

Statistical analysis

Descriptive statistics were applied to illustrate the sociodemographic and health characteristics of the enrolled participants. Differences of the characteristics across different cognitive status groups were assessed by Student’s t-test for continuous variables, and by χ2 test for categorical variables. Logistic regressions were used to examine the associations between BMI, WHR and cognitive impairment. BMI was evaluated as a categorical variable, divided by quartiles. WHR was evaluated under different BMI levels. Both BMI and WHR were assessed by three logistic models. In the basic model (model 1), no covariate was included when assessing the association between BMI and cognitive impairment, and BMI was adjusted when assessing the association between WHR and cognitive impairment. Model 2 was based on model 1, with additional adjusting for sociodemographic variables (age, sex, nation, education, marital status and family economics). Model 3 was based on model 2, with additional adjustments of lifestyles (smoking, drinking and physical exercise) and health variables (hypertension, stroke and depression).

All statistical analyses were performed by SAS V.9.4 (SAS Institute), and two-tailed p value <0.05 was considered statistically significant.

Patient and public involvement

No patients were involved in setting the research question or the outcome measures, nor were they involved in developing plans for design or implementation of the study. No patients were asked to advise on interpretation or writing up of results. There are no plans to disseminate the results of the research to study participants or the relevant patient community.

Results

Sociodemographics and health characteristics

Of the 9087 subjects, 1339 (14.7%) were defined as cognitive impairment by MMSE. The mean age of all subjects was 69.8 (±8.3). More than a half (51.9%) were female. Among the subjects with cognitive impairment, the mean MMSE score was 13.6 (±5.1), while the mean score was 25.8 (±3.1) in normal cognition group. The mean values of BMI and WHR were 22.7±3.6, 0.9±0.1, respectively, in the cognitive impairment group, and the mean values were 23.3±3.3, 0.9±0.1, respectively, in normal cognition group. Differences of BMI and WHR between the two groups were both statistically significant. The subjects with cognitive impairment tended to be older, female, minority ethnic group, without physical exercise, with hypertension, with stroke, with depression. Also, cognitive impairment was associated with education, marital status, family economics, smoking and drinking. More details are shown in table 1.

Table 1.

Sociodemographics and health characteristics of 9087 participants by cognitive status

Characteristics Normal cognition
(n=7748)
Cognitive impairment
(n=1339)
Overall P values
Age, years (mean, SD) 68.8±7.8 75.4±8.5 69.8±8.3 <0.001
Sex <0.001
 Male 3877 (50.0) 498 (37.2) 4375 (48.1)
 Female 3871 (50.0) 841 (62.8) 4712 (51.9)
Nation <0.001
 Han 7489 (96.7) 1213 (90.6) 8702 (95.8)
 Minority 259 (3.3) 126 (9.4) 385 (4.2)
Education <0.001
 Illiteracy 3703 (47.8) 893 (66.7) 4596 (50.6)
 Primary school 3461 (44.7) 379 (28.3) 3840 (42.3)
 Middle school or higher 584 (7.5) 67 (5.0) 651 (7.2)
Marital status <0.001
 Single 104 (1.4) 38 (2.8) 142 (1.6)
 Married 6060 (78.4) 776 (58.0) 6836 (75.4)
 Windowed/divorced 1566 (20.3) 525 (39.2) 2091 (23.1)
Family economics <0.001
 Rich 796 (10.3) 77 (5.8) 873 (9.6)
 Median 6135 (79.2) 984 (73.5) 7119 (78.4)
 Poor 817 (10.5) 277 (20.7) 1094 (12.0)
Smoking <0.001
 Current smokers 1749 (22.6) 173 (12.9) 1922 (21.2)
 Ex-smokers 768 (9.9) 121 (9.0) 889 (9.8)
 Never smokers 5231 (67.5) 1045 (78.0) 6276 (69.1)
Drinking <0.001
 Current drinkers 2079 (26.8) 204 (15.2) 2283 (25.1)
 Ex-drinkers 662 (8.5) 158 (11.8) 820 (9.0)
 Never drinkers 5007 (64.6) 977 (73.0) 5984 (65.9)
Physical exercise 1499 (19.4) 190 (14.2) 1689 (18.6) <0.001
Hypertension 3462 (44.7) 648 (48.4) 4110 (45.2) 0.011
Diabetes 667 (8.6) 113 (8.4) 780 (8.6) 0.838
Coronary heart disease 230 (3.0) 48 (3.6) 278 (3.1) 0.227
Stroke 204 (2.6) 91 (6.8) 295 (3.2) <0.001
Depression 664 (8.6) 275 (20.5) 939 (10.3) <0.001
Body mass index 23.3±3.3 22.7±3.6 23.2±3.4 <0.001
Waist-to-Hip ratio 0.9±0.1 0.9±0.1 0.9±0.1 0.026
MMSE score 25.8±3.1 13.6±5.1 24.0±5.6 <0.001

MMSE, Mini-Mental State Examination.

Association between BMI and cognitive impairment

The mean MMSE scores were calculated by quartiles of BMI. Subjects in the highest BMI quartile category had the highest mean MMSE score (24.36±5.28), and those in the lowest quartile category had the lowest mean MMSE value (23.33±5.94). Compared with the second quartile of BMI, the OR of the lowest quartile was 1.42 (95% CI, 1.21 to 1.67), the OR of the highest quartile was 0.86 (95% CI, 0.72 to 1.02) and the third quartile had an OR value of 0.92 (95% CI, 0.77 to 1.08). In model 3, the OR of Q1 BMI was close to being statistically significant, and these results were essentially unchanged after adjustment for more covariates (table 2).

Table 2.

Association between body mass index and cognitive impairment

Quartiles of body mass index, kg/m2 OR (95% CI)
Model 1*
(n=9087)
Model 2
(n=9068)
Model 3
(n=9068)
12.1–20.8 1.42 (1.21 to 1.67) 1.20 (1.01 to 1.42) 1.18 (0.99 to 1.40)
>20.8–22.9 1 1 1
>22.9–25.3 0.92 (0.77 to 1.08) 1.02 (0.85 to 1.22) 1.02 (0.85 to 1.22)
>25.3–42.8 0.86 (0.72 to 1.02) 0.95 (0.79 to 1.14) 0.93 (0.77 to 1.12)

*No covariate was included.

†Adjusted for age, sex, nation, education, marital status and family economics.

‡Based on model 2, model 3 was further adjusted for smoking, drinking, physical exercise, hypertension, stroke and depression.

Association between WHR and cognitive impairment

We detected two-way interaction between BMI and WHR, and the result was statistically significant (p=0.002). Further, the association between WHR and cognitive impairment was assessed under each BMI group. Under the lowest BMI group, the association between WHR and cognitive impairment was not statistically significant. Similar results were found in the second and third quartiles of BMI. In the highest BMI group, each 0.1 higher WHR corresponded to a 1.39-fold higher risk of cognitive impairment in the basic model. The OR value remained significant after adjusting for more covariates in model 2 and model 3 which were 1.36 (95% CI 1.10 to 1.69) and 1.37 (95% CI 1.10 to 1.71), respectively (table 3).

Table 3.

Association of waist-to-hip ratio (per 0.1 increase) with cognitive impairment under different body mass index groups

Quartiles of body mass index, kg/m2
12.1–20.8 >20.8–22.9 >22.9–25.3 >25.3–42.8
Subjects (n) 2244 2266 2311 2266
Waist-to-hip ratio
 Range 0.61–1.26 0.46–1.29 0.49–1.49 0.58–1.38
 Mean 0.87±0.07 0.89±0.06 0.91±0.06 0.93±0.06
Model 1* 1.13 (0.98–1.31) 1.12 (0.93–1.35) 1.38 (1.14–1.65) 1.39 (1.13–1.70)
Model 2 1.01 (0.86–1.18) 0.93 (0.75–1.13) 1.13 (0.94–1.41) 1.36 (1.10–1.69)
Model 3 0.99 (0.83–1.17) 0.92 (0.75–1.13) 1.14 (0.93–1.40) 1.37 (1.10–1.71)

*Adjusted for body mass index.

†Based on model 1, model 2 was further adjusted for age, sex, nation, education, marital status and family economics.

‡Based on model 2, model 3 was further adjusted for smoking, drinking, physical exercise, hypertension, stroke and depression.

Association between waist circumference and cognitive impairment

Similarly, we assessed the associations between waist circumference and cognitive impairment within various BMI levels. When BMI, age, sex, nation, education, marital status, family economics, smoking, drinking, physical exercise, hypertension, stroke and depression were controlled, each 1-unit higher waist circumference corresponded to a 1.02-fold higher risk of cognitive impairment among the elderly with BMI >22.9 kg/m2 (table 4).

Table 4.

Association of waist circumference with cognitive impairment under different body mass index groups

Quartiles of body mass index, kg/m2
12.1–20.8 >20.8–22.9 >22.9–25.3 >25.3–42.8
Subjects (n) 2244 2266 2311 2266
Model 1* 1.03 (1.01–1.05) 1.03 (1.01–1.05) 1.04 (1.02–1.06) 1.03 (1.01–1.04)
Model 2 1.02 (1.001–1.04) 1.02 (0.995–1.03) 1.03 (1.01–1.05) 1.02 (1.01–1.04)
Model 3 1.01 (0.996–1.03) 1.01 (0.993–1.03) 1.02 (1.004–1.05) 1.02 (1.01–1.04)

*Adjusted for body mass index.

†Based on model 1, model 2 was further adjusted for age, sex, nation, education, marital status and family economics.

‡Based on model 2, model 3 was further adjusted for smoking, drinking, physical exercise, hypertension, stroke and depression.

Discussion

In this cross-sectional study of 9087 Chinese elderly aged 60 years and older, we investigated the associations between BMI, WHR and cognitive impairment risk. We found that each 0.1-unit increase in WHR corresponded to 1.37 (1.10–1.71) evaluated cognitive impairment risk in high BMI (>25.3 kg/m2) group in the fully adjusted model (model 3).

In our study, compared with Q2 BMI (>20.8–22.9 kg/m2), Q1 BMI (≤20.8 kg/m2) was a risk factor for cognitive impairment, while Q4 BMI tended to be a protective factor, though not statistically significant. In previous studies, some reported that high BMI tended to be a risk factor for cognitive decline,9–11 while others observed a negative association between high BMI and cognitive function.4 5 7 8 The inconsistency suggests the complex relationship between BMI and cognitive function.

Zhou et al 21 suggested that subjects who were both with obesity and dementia had a high mortality rate which might very likely remove those with high BMI and dementia, and leave moderate or severe dementia subjects with low BMI, thus enforce the association between BMI and dementia. Assuming the survivor bias existed, the observed association between high BMI and cognition impairment would be biased towards the null, and such bias would be even more serious in cross-sectional study if it exists. Nevertheless, the hypothesis is not enough to explain the relationship between low BMI and cognitive impairment. Furthermore, several cohort studies reported that both persons with low BMI and persons with high BMI had lower cognitive functions in later life.22–26

Among the participants of this study, the mean value of WHR tended to increase within the higher BMI group. We observed a strong positive association between WHR and cognitive impairment risk under Q4 BMI (>25.3 kg/m2) group. The association remained after adjusting for covariates. Similar results were observed when evaluating the association between waist circumference and cognitive impairment. These findings led us to speculate that body fat and muscle had a reverse effect on cognition. Adipokines might be a link between body fat and dementia. Adipokines include hundreds of polypeptides secreted by the cells of white adipose tissue. The action of adipokines could be altered during neurodegenerative events and might feedback to contribute to neurodegeneration.27 Age-related reduction of muscle mass and strength is a major public health concern in older persons. The association between muscle and cognition could mainly be derived from muscle strength. Boyle et al 28 found that high muscle strength decreased the risk of alzheimer’s disease (AD), and Chen et al 29 had similar findings.

It is noteworthy to mention that previous studies have reported high-fat diet exacerbates cognitive decline.30 31 Amyloid deposition and cerebral microvasculature dysfunction are the most discussed mechanisms in relevant studies.30–33 These findings suggest further studies are needed to explore the mechanisms that underlie the association between obesity and cognitive impairment.

Some limitations of the present study should be noted. One limitation is that high-fat diet, which is an important influence factor for cognitive function as mentioned above, was not included in this study. It is probable that high-fat diet leads to central obesity with high BMI and WHR among Chinese elderly. Further studies are needed to explore the relationship within diet, WHR and cognitive impairment. Besides, caution would be needed when generalising the present findings, as our results were based on a cross-sectional study.

Conclusions

Higher WHR significantly increases the risk of cognitive impairment among the elderly with BMI >25.3 kg/m2. The results of this study suggest that it is of benefit to the elderly with high BMI to control WHR.

Supplementary Material

Reviewer comments
Author's manuscript

Acknowledgments

We acknowledge the invaluable contributions made by all the interviewers of the Zhejiang Ageing and Health Cohort Study.

Footnotes

Contributors: JL, RY, TZ, QC, XY, YZ, FL, XW, FH and CY participated in the design of the study, collection of data, data cleaning. TZ, RY, YZ, FL, XW and CY conducted the statistical analyses. TZ wrote the manuscript. RY, QC, XY and JL contributed to the interpretation of the results and revised the manuscript critically. All authors approved the final version of the manuscript.

Funding: This work was supported by Zhejiang Provincial Medical and Health Science and Technology Project (2015KYB081, 2017KY285, 2017RC018), Zhejiang Provincial Natural Science Foundation of China (Q19H260002), and Science and Technology Bureau of Yuhuan (201731).

Competing interests: None declared.

Patient consent: Obtained.

Ethics approval: Ethics Committee of Zhejiang Provincial Center for Disease Control and Prevention.

Provenance and peer review: Not commissioned; externally peer reviewed.

Data sharing statement: Data are not publicly available due to local ethical restrictions.

References

  • 1. Herrera AC, Prince M, Knapp M, et al. . World Alzheimer Report 2016: Improving healthcare for people with dementia Coverage, quality and costs now and in the future, 2016. [Google Scholar]
  • 2. Chan KY, Wang W, Wu JJ, et al. . Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet 2013;381:2016–23. 10.1016/S0140-6736(13)60221-4 [DOI] [PubMed] [Google Scholar]
  • 3. Nie H, Xu Y, Liu B, et al. . The prevalence of mild cognitive impairment about elderly population in China: a meta-analysis. Int J Geriatr Psychiatry 2011;26:558–63. 10.1002/gps.2579 [DOI] [PubMed] [Google Scholar]
  • 4. Qizilbash N, Gregson J, Johnson ME, et al. . BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol 2015;3:431–6. 10.1016/S2213-8587(15)00033-9 [DOI] [PubMed] [Google Scholar]
  • 5. Tolppanen AM, Ngandu T, Kåreholt I, et al. . Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. J Alzheimers Dis 2014;38:201–9. 10.3233/JAD-130698 [DOI] [PubMed] [Google Scholar]
  • 6. Monda V, La Marra M, Perrella R, et al. . Obesity and brain illness: from cognitive and psychological evidences to obesity paradox. Diabetes Metab Syndr Obes 2017;10:473–9. 10.2147/DMSO.S148392 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Tikhonoff V, Casiglia E, Guidotti F, et al. . Body fat and the cognitive pattern: A population-based study. Obesity 2015;23:1502–10. 10.1002/oby.21114 [DOI] [PubMed] [Google Scholar]
  • 8. Kim S, Kim Y, Park SM. Body mass index and decline of cognitive function. PLoS One 2016;11:e0148908 10.1371/journal.pone.0148908 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Gunstad J, Lhotsky A, Wendell CR, et al. . Longitudinal examination of obesity and cognitive function: results from the Baltimore longitudinal study of aging. Neuroepidemiology 2010;34:222–9. 10.1159/000297742 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Gallucci M, Mazzuco S, Ongaro F, et al. . Body mass index, lifestyles, physical performance and cognitive decline: The “Treviso Longeva (Trelong)” study. J Nutr Health Aging 2013;17:378–84. 10.1007/s12603-012-0397-1 [DOI] [PubMed] [Google Scholar]
  • 11. Besser LM, Gill DP, Monsell SE, et al. . Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord 2014;28:36–43. 10.1097/WAD.0000000000000005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Smith E, Hay P, Campbell L, et al. . A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment. Obes Rev 2011;12:740–55. 10.1111/j.1467-789X.2011.00920.x [DOI] [PubMed] [Google Scholar]
  • 13. Benito-León J, Mitchell AJ, Hernández-Gallego J, et al. . Obesity and impaired cognitive functioning in the elderly: a population-based cross-sectional study (NEDICES). Eur J Neurol 2013;20:899–e77. 10.1111/ene.12083 [DOI] [PubMed] [Google Scholar]
  • 14. Turcato E, Bosello O, Di Francesco V, et al. . Waist circumference and abdominal sagittal diameter as surrogates of body fat distribution in the elderly: their relation with cardiovascular risk factors. Int J Obes Relat Metab Disord 2000;24:1005–10. 10.1038/sj.ijo.0801352 [DOI] [PubMed] [Google Scholar]
  • 15. Villareal DT, Apovian CM, Kushner RF, et al. . Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J Clin Nutr 2005;82:923–34. 10.1093/ajcn/82.5.923 [DOI] [PubMed] [Google Scholar]
  • 16. Sharma S, Batsis JA, Coutinho T, et al. . Normal-weight central obesity and mortality risk in older adults with coronary artery disease. Mayo Clin Proc 2016;91:343–51. 10.1016/j.mayocp.2015.12.007 [DOI] [PubMed] [Google Scholar]
  • 17. Sahakyan KR, Somers VK, Rodriguez-Escudero JP, et al. . Normal-weight central obesity: implications for total and cardiovascular mortality. Ann Intern Med 2015;163:827–35. 10.7326/M14-2525 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Zhengyu W, mingyuan Z. Application of Chinese version of Mini-Mental State examination (MMSE). Shanghai Archives of Psychiatry 1989;3:108–11. [Google Scholar]
  • 19. Li FD, He F, Chen TR, et al. . Reproductive history and risk of cognitive impairment in elderly women: a cross-sectional study in eastern China. J Alzheimers Dis 2016;49:139–47. 10.3233/JAD-150444 [DOI] [PubMed] [Google Scholar]
  • 20. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Zhou Y, Flaherty JH, Huang CQ, et al. . Association between body mass index and cognitive function among Chinese nonagenarians/centenarians. Dement Geriatr Cogn Disord 2010;30:517–24. 10.1159/000322110 [DOI] [PubMed] [Google Scholar]
  • 22. Sabia S, Nabi H, Kivimaki M, et al. . Health behaviors from early to late midlife as predictors of cognitive function: The Whitehall II study. Am J Epidemiol 2009;170:428–37. 10.1093/aje/kwp161 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Dahl AK, Hassing LB, Fransson EI, et al. . Body mass index across midlife and cognitive change in late life. Int J Obes 2013;37:296–302. 10.1038/ijo.2012.37 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Sturman MT, de Leon CF, Bienias JL, et al. . Body mass index and cognitive decline in a biracial community population. Neurology 2008;70:360–7. 10.1212/01.wnl.0000285081.04409.bb [DOI] [PubMed] [Google Scholar]
  • 25. Arvanitakis Z, Capuano AW, Bennett DA, et al. . Body mass index and decline in cognitive function in older black and white persons. J Gerontol A Biol Sci Med Sci 2018;73:198-203 10.1093/gerona/glx152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Wang F, Zhao M, Han Z, et al. . Association of body mass index with amnestic and non-amnestic mild cognitive impairment risk in elderly. BMC Psychiatry 2017;17:334 10.1186/s12888-017-1493-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Kiliaan AJ, Arnoldussen IA, Gustafson DR. Adipokines: a link between obesity and dementia? Lancet Neurol 2014;13:913–23. 10.1016/S1474-4422(14)70085-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Boyle PA, Buchman AS, Wilson RS, et al. . Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch Neurol 2009;66:1339 10.1001/archneurol.2009.240 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Chen WL, Peng TC, Sun YS, et al. . Examining the association between quadriceps strength and cognitive performance in the elderly. Medicine 2015;94:e1335 10.1097/MD.0000000000001335 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Thériault P, ElAli A, Rivest S. High fat diet exacerbates Alzheimer’s disease-related pathology in APPswe/PS1 mice. Oncotarget 2016;7:67808–27. doi:10.18632/oncotarget.12179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Lin B, Hasegawa Y, Takane K, et al. . High-fat-diet intake enhances cerebral amyloid angiopathy and cognitive impairment in a mouse model of alzheimer’s disease, independently of metabolic disorders. J Am Heart Assoc 2016;5:e003154 10.1161/JAHA.115.003154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Pimentel-Coelho PM, Rivest S. The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease. Eur J Neurosci 2012;35:1917–37. 10.1111/j.1460-9568.2012.08126.x [DOI] [PubMed] [Google Scholar]
  • 33. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci 2011;12:723–38. 10.1038/nrn3114 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Reviewer comments
Author's manuscript

Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES